📄 Paper Brief | Nature Nanotechnology (2021) | Team from Caltech and others

🔬 Research Rationale: Molecular/cell-based therapies offer high precision but lack spatial control, while focused ultrasound (FUS) achieves deep penetration but lacks molecular specificity. The authors ingeniously combined the two approaches, using genetically encoded gas vesicles (GVs) as "fuses" for low-acoustic-pressure FUS. Local inertial cavitation (bubble explosion) was induced to enable precise mechanical therapy and drug release.

✨ Key Research Highlights ① Clear mechanism: Low-frequency FUS (670 kHz) collapses GVs, releasing gas for nucleation to form micron-sized bubbles and generate potent localized mechanical damage. ② Cell-scale "bombs": Targeted GVs attach to tumor cells, and ultrasound stimulation successfully "blows open" cell membranes. ③ Genetically engineered bacteria: Salmonella expressing GVs lyse under ultrasound (a 42% drop in survival rate), with intracellular luciferase effectively released. ④ In vivo anti-tumor efficacy: Tumor-homing probiotic EcN expressing GVs, combined with ultrasound and immune checkpoint inhibitors, slowed tumor growth by approximately threefold and more than doubled median survival.

🧬 Key Notes on Material Development Core material: Gas vesicles (GVs, roughly 200–800 nm), gas-filled protein nanostructures derived from cyanobacteria. Targeted modification: Genetic engineering displays RGD peptides on the GvpC shell to target αVβ3 integrin on tumor cells. Host chassis cells: Engineered bacteria (Salmonella, EcN) or mammalian cells that express GVs, acting as intracellular mechanical "explosives".

6. English Title: Acoustically triggered mechanotherapy using genetically encoded gas vesicles

#Gas #UltrasoundCavitation #CancerTherapy #SyntheticBiology #ScientificResearch #sci #ResearchStudy

We provide full-process services for custom material design, including innovative scheme design, fabrication, characterization, and in vitro & in vivo validation (cell and animal studies). Our postdoctoral team with multiple high-impact Q1 publications can tackle your challenging research demands. Our scope covers hydrogels, drug delivery systems, nanomaterials, polymers, liposomes, microneedles and more. We support project design, NSFC proposal writing, and high-quality SCI manuscripts for journals such as AFM, AM and other Q1/Q2 journals. Enquiries are welcome👇

17768014569 (Dr.Gao)

17761925168 (Dr. Zhang)

18013729810 (Dr. Yang)